Aurobindo gets approval in Citalopram oral solution

By Elaine Rigoli

Tampa, Fla., Sept. 12 - The Food and Drug Administration has approved Aurobindo Pharma Ltd.'s Citalopram oral solution 10 mg/5 ml.

The company already has approval of Citalopram tablets of 10, 20, and 40 mg strengths in tablet form.

Citalopram belongs to a class of medication called selective serotonin reuptake inhibitors, indicated in the treatment of depressive disorders.

The Hyderabad, India, pharmaceutical company said Citalopram is a generic equivalent of Forest Laboratories' Celexa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.